Vivek Ramaswamy's Net Worth
$605 Million
Who is Vivek Ramaswamy?
Vivek Ramaswamy has an estimated net worth of $605 Million. This is based on reported shares across multiple companies, which include Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., and Axovant Sciences Ltd..
SEC CIK
Vivek Ramaswamy's CIK is 0001635075
Past Insider Trading and Trends
2023 was Vivek Ramaswamy's most active year for acquiring shares with 4 total transactions. Vivek Ramaswamy's most active month to acquire stocks was the month of May. 2023 was Vivek Ramaswamy's most active year for disposing of shares, totalling 10 transactions. Vivek Ramaswamy's most active month to dispose stocks was the month of August. 2023 saw Vivek Ramaswamy paying a total of $0.00 for 754,508 shares, this is the most they've acquired in one year. In 2023 Vivek Ramaswamy cashed out on 6,665,126 shares for a total of $51,652,722.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arbutus Biopharma Corp (ABUS) Snapshot price: $2.4912
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Roivant Sciences Ltd. (ROIV) Snapshot price: $10.395
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -5.46% | -3.00M |
$11.05 | -$33,150,000.00 | 51.93M |
Jan 2
| |||
Form 4
| +0.26% | 141.32K |
$11.58 | -$1,550,689.38 | 54.93M |
Dec 27
| |||
Form 4
| +0.11% | 57.59K |
$12.67 | -$784,868.49 | 54.79M |
Sep 27 - Sep 28
| |||
Form 4
| +0.07% | 39.02K |
$11.25 | -$536,535.00 | 54.73M |
Aug 27 - Aug 28
| |||
Form 4
| +0.16% | 90.03K |
$11.43 | -$868,942.89 | 54.69M |
Jul 27 - Jul 31
| |||
Form 4
| +0.35% | 192.26K |
$9.09 | -$1,726,618.23 | 54.6M |
May 27 - May 31
| |||
Form 4
| -6.85% | -4.00M |
$7.95 | -$31,800,000.00 | 54.41M |
Feb 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axovant Sciences Ltd. (SIOX) Snapshot price: $0.45
Principal Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||